EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression

Epithelial-to-mesenchymal transition (EMT) is associated with metastasis formation as well as with generation and maintenance of cancer stem cells. In this way, EMT contributes to tumor invasion, heterogeneity and chemoresistance. Morphological and functional changes involved in these processes require robust reprogramming of gene expression, which is only partially accomplished at the transcriptional level. Alternative splicing is another essential layer of gene expression regulation that expands the cell proteome. This step in post-transcriptional regulation of gene expression tightly controls cell identity between epithelial and mesenchymal states and during stem cell differentiation. Importantly, dysregulation of splicing factor function and cancer-specific splicing isoform expression frequently occurs in human tumors, suggesting the importance of alternative splicing regulation for cancer biology.In this review, we briefly discuss the role of EMT programs in development, stem cell differentiation and cancer progression. Next, we focus on selected examples of key factors involved in EMT and stem cell differentiation that are regulated post-transcriptionally through alternative splicing mechanisms. Lastly, we describe relevant oncogenic splice-variants that directly orchestrate cancer stem cell biology and tumor EMT, which may be envisioned as novel targets for therapeutic intervention.

[1]  M. Balda,et al.  Tight junctions: from simple barriers to multifunctional molecular gates , 2016, Nature Reviews Molecular Cell Biology.

[2]  R. Carstens,et al.  Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors , 2012, Proceedings of the National Academy of Sciences.

[3]  J. Cheville,et al.  A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease* , 2008, Journal of Biological Chemistry.

[4]  C. Ghigna,et al.  Sam68 regulates EMT through alternative splicing–activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene , 2010, The Journal of cell biology.

[5]  Masato Yano,et al.  Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. , 2012, Genes & development.

[6]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[7]  D. Levasseur,et al.  Alternative Splicing Produces Nanog Protein Variants with Different Capacities for Self-renewal and Pluripotency in Embryonic Stem Cells* , 2011, The Journal of Biological Chemistry.

[8]  Richard J. Jones,et al.  Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations , 2013, Oncotarget.

[9]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[10]  F. Rigo,et al.  Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects. , 2014, Advances in experimental medicine and biology.

[11]  Li Li,et al.  Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion , 2012, Archives of Gynecology and Obstetrics.

[12]  O. Silvennoinen,et al.  The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells , 2014, Oncogene.

[13]  C. Sette,et al.  Alternative splicing and cell survival: from tissue homeostasis to disease , 2016, Cell Death and Differentiation.

[14]  C. Erickson,et al.  MMP‐2 plays an essential role in producing epithelial‐mesenchymal transformations in the avian embryo , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[15]  B. Frey,et al.  Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. , 2004, Molecular cell.

[16]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[17]  J. Valcárcel,et al.  Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks , 2016, Genome research.

[18]  S. Zucker,et al.  Role of matrix metalloproteinases (MMPs) in colorectal cancer , 2004, Cancer and Metastasis Reviews.

[19]  U. Tepass,et al.  Adherens junctions: from molecules to morphogenesis , 2010, Nature Reviews Molecular Cell Biology.

[20]  F. Rousset,et al.  RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues , 2012, Molecular and Cellular Biology.

[21]  Luc Girard,et al.  ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. , 2016, The Journal of clinical investigation.

[22]  D. Black,et al.  The neurogenetics of alternative splicing , 2016, Nature Reviews Neuroscience.

[23]  M. Nieto,et al.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.

[24]  Abigail J. Deloria,et al.  Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer , 2016, Oncotarget.

[25]  Eric T. Wang,et al.  Global regulation of alternative splicing during myogenic differentiation , 2010, Nucleic acids research.

[26]  T. Hagemann,et al.  The tumor microenvironment at a glance , 2012, Journal of Cell Science.

[27]  Valeri Vasioukhin,et al.  Cell polarity and cancer – cell and tissue polarity as a non-canonical tumor suppressor , 2008, Journal of Cell Science.

[28]  L. Maquat,et al.  The multiple lives of NMD factors: balancing roles in gene and genome regulation , 2008, Nature Reviews Genetics.

[29]  E. Brambilla,et al.  Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma , 2012, PloS one.

[30]  I. Weissman,et al.  Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation , 2009, Proceedings of the National Academy of Sciences.

[31]  J. Frisén,et al.  Deconstructing stemness , 2005, The EMBO journal.

[32]  M. Ringnér,et al.  CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers , 2011, BMC Cancer.

[33]  M. Parsons,et al.  Cadherin Switch during EMT in Neural Crest Cells Leads to Contact Inhibition of Locomotion via Repolarization of Forces , 2015, Developmental cell.

[34]  Harold Varmus,et al.  Seeding and Propagation of Untransformed Mouse Mammary Cells in the Lung , 2008, Science.

[35]  T. Keck,et al.  ZEB1 in Pancreatic Cancer , 2010, Cancers.

[36]  F. Portillo,et al.  Transcriptional regulation of cell polarity in EMT and cancer , 2008, Oncogene.

[37]  C. Sette,et al.  The RNA-binding protein Sam68 is a multifunctional player in human cancer. , 2011, Endocrine-related cancer.

[38]  A. Ben-Ze'ev,et al.  Epithelial-mesenchymal transition and the invasive potential of tumors. , 2008, Trends in molecular medicine.

[39]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[40]  U. Schmitz,et al.  A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages. , 2015, Blood.

[41]  Luigi Coppola,et al.  Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. , 2011, Cancer research.

[42]  T. Nilsen,et al.  Expansion of the eukaryotic proteome by alternative splicing , 2010, Nature.

[43]  C. Ghigna,et al.  Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT) , 2012, Cellular and Molecular Life Sciences.

[44]  Jun Yao,et al.  G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. , 2012, The Journal of clinical investigation.

[45]  L. Miller,et al.  Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas. , 2007, Cancer research.

[46]  Guojun Sheng,et al.  Epithelial to mesenchymal transition during gastrulation: An embryological view , 2008, Development, growth & differentiation.

[47]  Richard A. Moore,et al.  Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal , 2015, Proceedings of the National Academy of Sciences.

[48]  M. Assanah,et al.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer , 2010, Nature.

[49]  Z. Shao,et al.  Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma , 2004, Breast Cancer Research and Treatment.

[50]  Jernej Ule,et al.  Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis. , 2014, Molecular cell.

[51]  Lily Shiue,et al.  Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation. , 2013, RNA.

[52]  A. Mele,et al.  Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer , 2014, eLife.

[53]  Jessica M. Rusert,et al.  A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition. , 2013, Cell stem cell.

[54]  Davalyn R. Powell,et al.  Riding the crest of the wave: parallels between the neural crest and cancer in epithelial-to-mesenchymal transition and migration , 2013, Wiley interdisciplinary reviews. Systems biology and medicine.

[55]  Gene W. Yeo,et al.  Alternative splicing in stem cell self-renewal and diferentiation. , 2010, Advances in experimental medicine and biology.

[56]  M. Ares,et al.  Context-dependent control of alternative splicing by RNA-binding proteins , 2014, Nature Reviews Genetics.

[57]  Jeffrey M. Rosen,et al.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.

[58]  D. Radisky,et al.  Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression , 2012, Science Translational Medicine.

[59]  M. Wood,et al.  An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies. , 2015, Current opinion in pharmacology.

[60]  C. Rabouille,et al.  Extracellular cleavage of E-cadherin promotes epithelial cell extrusion , 2014, Journal of Cell Science.

[61]  D. Radisky,et al.  Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[62]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[63]  M. Garcia-Blanco,et al.  Receptor 2 Exon Iiic to Silence Fibroblast Growth Factor Hnrnp H and Hnrnp F Complex with Fox2 Supplemental Material , 2008 .

[64]  B. Zhou,et al.  Epigenetic regulation of EMT: the Snail story. , 2014, Current pharmaceutical design.

[65]  Y. Toiyama,et al.  Radiation induces epithelial-mesenchymal transition in colorectal cancer cells. , 2011, Oncology reports.

[66]  Randy J. Read,et al.  Transcriptional diversity during lineage commitment of human blood progenitors , 2014, Science.

[67]  Russ P Carstens,et al.  Functional roles of alternative splicing factors in human disease , 2015, Wiley interdisciplinary reviews. RNA.

[68]  Claude C. Warzecha,et al.  The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development , 2015, eLife.

[69]  Jeffrey L. Wrana,et al.  An Alternative Splicing Switch Regulates Embryonic Stem Cell Pluripotency and Reprogramming , 2011, Cell.

[70]  A. Masuda,et al.  CUGBP1 and MBNL1 preferentially bind to 3′ UTRs and facilitate mRNA decay , 2012, Scientific Reports.

[71]  I. Fabregat,et al.  Snail1 suppresses TGF-β-induced apoptosis and is sufficient to trigger EMT in hepatocytes , 2010, Development.

[72]  Jun Yao,et al.  Tumor-Specific Isoform Switch of the Fibroblast Growth Factor Receptor 2 Underlies the Mesenchymal and Malignant Phenotypes of Clear Cell Renal Cell Carcinomas , 2013, Clinical Cancer Research.

[73]  J. Manley,et al.  Determinants of SR protein specificity. , 1999, Current opinion in cell biology.

[74]  R. Gomis,et al.  Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. , 2012, The Journal of clinical investigation.

[75]  B. Blencowe,et al.  Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming , 2015, Genes & development.

[76]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[77]  Jialiang Liang,et al.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. , 2010, Cell stem cell.

[78]  D. Planchard,et al.  Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.

[79]  G. Berx,et al.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells , 2005, Oncogene.

[80]  I. Herr,et al.  Triptolide reverses hypoxia-induced epithelial–mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation , 2013, International journal of cancer.

[81]  J. Visvader,et al.  Cancer stem cells: current status and evolving complexities. , 2012, Cell stem cell.

[82]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[83]  K. Mostov,et al.  From cells to organs: building polarized tissue , 2008, Nature Reviews Molecular Cell Biology.

[84]  C. D’Souza-Schorey,et al.  Lysosomal Targeting of E-Cadherin: a Unique Mechanism for the Down-Regulation of Cell-Cell Adhesion during Epithelial to Mesenchymal Transitions , 2005, Molecular and Cellular Biology.

[85]  S. Tavazoie,et al.  Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts , 2016, Genes & development.

[86]  Eric T. Wang,et al.  MBNL proteins repress ES-cell-specific alternative splicing and reprogramming , 2013, Nature.

[87]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[88]  J. Manley,et al.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. , 2010, Genes & development.

[89]  C. Ghigna,et al.  Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: Therapeutic potential of bifunctional oligonucleotides and indole derivatives , 2010, RNA biology.

[90]  E. Pilozzi,et al.  Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells , 2015, Oncogene.

[91]  A. Danilkovitch-Miagkova.  Oncogenic signaling pathways activated by RON receptor tyrosine kinase. , 2003, Current cancer drug targets.

[92]  T. Shibata,et al.  TGF-β regulates isoform switching of FGF receptors and epithelial–mesenchymal transition , 2011, The EMBO journal.

[93]  C. Watson,et al.  Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines. , 2006, Differentiation; research in biological diversity.

[94]  Kakajan Komurov,et al.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.

[95]  P. Chieffi,et al.  The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival , 2013, Nucleic acids research.

[96]  Jiuhong Kang,et al.  Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma , 2013, Molecular Biology Reports.

[97]  A. Krainer,et al.  RNA therapeutics: beyond RNA interference and antisense oligonucleotides , 2012, Nature Reviews Drug Discovery.

[98]  J. Clements,et al.  Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.

[99]  F. Modugno,et al.  Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo , 2008, Clinical & Experimental Metastasis.

[100]  A. Krainer,et al.  THE SPLICING FACTOR SRSF1 REGULATES APOPTOSIS AND PROLIFERATION TO PROMOTE MAMMARY EPITHELIAL CELL TRANSFORMATION , 2011, Nature Structural &Molecular Biology.

[101]  M. Moyer,et al.  Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells , 2013, RNA.

[102]  J. Thiery,et al.  Xenopus cadherin-11 is expressed in different populations of migrating neural crest cells , 1998, Mechanisms of Development.

[103]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[104]  M. Gerstein,et al.  Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing , 2010, Proceedings of the National Academy of Sciences.

[105]  Catalin C. Barbacioru,et al.  Tracing the Derivation of Embryonic Stem Cells from the Inner Cell Mass by Single-Cell RNA-Seq Analysis , 2010, Cell stem cell.

[106]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[107]  Gene W. Yeo,et al.  Genome-wide analysis reveals SR protein cooperation and competition in regulated splicing. , 2013, Molecular cell.

[108]  T. Inoue,et al.  Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. , 1999, International journal of molecular medicine.

[109]  E. Lander,et al.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.

[110]  D. Scholtens,et al.  Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. , 2014, The Journal of clinical investigation.

[111]  C. Gottardi,et al.  Molecular components of the adherens junction. , 2008, Biochimica et biophysica acta.

[112]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[113]  Russ P. Carstens,et al.  An Intronic Splicing Silencer Causes Skipping of the IIIb Exon of Fibroblast Growth Factor Receptor 2 through Involvement of Polypyrimidine Tract Binding Protein , 2000, Molecular and Cellular Biology.

[114]  S. Alahari,et al.  Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications , 2016, Molecular Cancer.

[115]  R. Lothe,et al.  Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes , 2016, Oncogene.

[116]  R. Maestro,et al.  Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. , 2008, Cancer cell.

[117]  J. Collins,et al.  RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell Reprogramming. , 2016, Cell reports.

[118]  N. Copeland,et al.  Scrib is required for epithelial cell identity and prevents epithelial to mesenchymal transition in the mouse. , 2013, Developmental biology.

[119]  C. Stern,et al.  Interactions between Wnt and Vg1 signalling pathways initiate primitive streak formation in the chick embryo. , 2001, Development.

[120]  P. Jordan,et al.  Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors , 1999, Oncogene.

[121]  Michael R Green,et al.  Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. , 2005, Molecular cell.

[122]  X. Bian,et al.  EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin , 2012, Oncogene.

[123]  B. Blencowe,et al.  The alternative splicing factor Nova2 regulates vascular development and lumen formation , 2015, Nature Communications.

[124]  B. Margolis,et al.  Tight junctions and cell polarity. , 2006, Annual review of cell and developmental biology.

[125]  A. Krainer,et al.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene , 2007, Nature Structural &Molecular Biology.

[126]  C. Ghigna,et al.  Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy , 2013, International journal of cell biology.

[127]  Ronit Vogt Sionov,et al.  Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. , 2008, Seminars in cancer biology.

[128]  Chaya Kalcheim,et al.  Epithelial–Mesenchymal Transitions during Neural Crest and Somite Development , 2015, Journal of clinical medicine.

[129]  C. Ghigna,et al.  SAM68: Signal Transduction and RNA Metabolism in Human Cancer , 2015, BioMed research international.

[130]  G. Berx,et al.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.

[131]  S. Ranade,et al.  Stem cell transcriptome profiling via massive-scale mRNA sequencing , 2008, Nature Methods.

[132]  K. Miyazono,et al.  TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP , 2011, Oncogene.

[133]  S. Yamanaka,et al.  Global splicing pattern reversion during somatic cell reprogramming. , 2013, Cell reports.

[134]  Christopher J. Lee,et al.  Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data. , 2004, Nucleic acids research.

[135]  J. Mulshine,et al.  hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines. , 2010, Cancer research.

[136]  Dan Chen,et al.  The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. , 2014, Cancer cell.

[137]  Chonghui Cheng,et al.  CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. , 2011, The Journal of clinical investigation.

[138]  A. del Sol,et al.  Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival , 2015, PloS one.

[139]  M. Salto‐Tellez,et al.  CD44v8-10 is a cancer-specific marker for gastric cancer stem cells. , 2014, Cancer research.

[140]  M. Korc,et al.  Epithelial Splicing Regulatory Protein 1 is a Favorable Prognostic Factor in Pancreatic Cancer that Attenuates Pancreatic Metastases , 2013, Oncogene.

[141]  W. Nelson,et al.  Remodeling epithelial cell organization: transitions between front-rear and apical-basal polarity. , 2009, Cold Spring Harbor perspectives in biology.

[142]  Carl-Philipp Heisenberg,et al.  Three Functions of Cadherins in Cell Adhesion , 2013, Current Biology.

[143]  M. Ozawa,et al.  The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation , 2004, Journal of Cell Science.

[144]  Shoichiro Tsukita,et al.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail , 2003, Journal of Cell Science.

[145]  R. Weinberg,et al.  Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. , 2012, Seminars in cancer biology.

[146]  P. Andrews,et al.  OCT4 Spliced Variants Are Differentially Expressed in Human Pluripotent and Nonpluripotent Cells , 2008, Stem cells.

[147]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[148]  K. Pantel,et al.  Micrometastasis in breast cancer and other solid tumors. , 2004, Journal of biological regulators and homeostatic agents.

[149]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2015, Nature.

[150]  A. Ridley,et al.  Rho GTPase signalling in cell migration , 2015, Current opinion in cell biology.

[151]  Shuying Sun,et al.  SRSF1-Regulated Alternative Splicing in Breast Cancer. , 2015, Molecular cell.

[152]  Auinash Kalsotra,et al.  Functional consequences of developmentally regulated alternative splicing , 2011, Nature Reviews Genetics.

[153]  D. Peeper,et al.  Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths , 2010, Aging.

[154]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[155]  M. Ikura,et al.  Dynamic and Static Interactions between p120 Catenin and E-Cadherin Regulate the Stability of Cell-Cell Adhesion , 2010, Cell.

[156]  Juergen A. Knoblich,et al.  Genome-Wide Analysis of Self-Renewal in Drosophila Neural Stem Cells by Transgenic RNAi , 2011, Cell stem cell.

[157]  P. Sharp,et al.  Building Robust Transcriptomes with Master Splicing Factors , 2014, Cell.

[158]  L. Hawthorn,et al.  Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells , 2007, Oncogene.

[159]  C. Klein,et al.  Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.

[160]  D. Rio,et al.  Mechanisms and Regulation of Alternative Pre-mRNA Splicing. , 2015, Annual review of biochemistry.

[161]  Eshel Ben-Jacob,et al.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..

[162]  R. Breathnach,et al.  Combined Use of MS2 and PP7 Coat Fusions Shows that TIA-1 Dominates hnRNP A1 for K-SAM Exon Splicing Control , 2010, Journal of biomedicine & biotechnology.

[163]  Angélica Figueroa,et al.  Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition , 2013, Cellular and Molecular Life Sciences.

[164]  Chaolin Zhang,et al.  Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. , 2014, Molecular cell.

[165]  Jean Paul Thiery,et al.  Early events in cell adhesion and polarity during epithelial-mesenchymal transition , 2012, Journal of Cell Science.

[166]  S. Hung,et al.  RBM4 Regulates Neuronal Differentiation of Mesenchymal Stem Cells by Modulating Alternative Splicing of Pyruvate Kinase M , 2016, Molecular and Cellular Biology.

[167]  Claude C. Warzecha,et al.  The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events , 2009, RNA biology.

[168]  B. Cieply,et al.  Multiphasic and Dynamic Changes in Alternative Splicing during Induction of Pluripotency Are Coordinated by Numerous RNA-Binding Proteins. , 2016, Cell reports.

[169]  L. weiswald,et al.  Spherical Cancer Models in Tumor Biology1 , 2015, Neoplasia.

[170]  A. Krainer,et al.  Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. , 2012, Cell reports.

[171]  Chi Wang,et al.  Interaction with Suv39H1 is Critical for Snail-mediated E-cadherin Repression in Breast Cancer , 2012, Oncogene.

[172]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[173]  S. Weissman,et al.  Transcriptome Signature and Regulation in Human Somatic Cell Reprogramming , 2015, Stem cell reports.

[174]  Nicolas Fossat,et al.  C to U RNA editing mediated by APOBEC1 requires RNA‐binding protein RBM47 , 2014, EMBO reports.

[175]  S. Li,et al.  Numb regulates cell–cell adhesion and polarity in response to tyrosine kinase signalling , 2009, The EMBO journal.

[176]  N. Jordan,et al.  Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer , 2011, Cell cycle.

[177]  C. Ghigna,et al.  HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition , 2013, Nucleic acids research.

[178]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions: insights from development , 2012, Development.

[179]  D. Radisky,et al.  Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. , 2012, Cold Spring Harbor perspectives in biology.

[180]  Yi Xing,et al.  Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition , 2016, Molecular and Cellular Biology.

[181]  Dong Wang,et al.  Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential , 2003, Oncogene.

[182]  Benjamin J. Blencowe,et al.  Dynamic Integration of Splicing within Gene Regulatory Pathways , 2013, Cell.

[183]  V. LeBleu,et al.  EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.

[184]  H. Allgayer,et al.  MicroRNAs-10a and -10b Contribute to Retinoic Acid-induced Differentiation of Neuroblastoma Cells and Target the Alternative Splicing Regulatory Factor SFRS1 (SF2/ASF)* , 2010, The Journal of Biological Chemistry.

[185]  A. Francis Stewart,et al.  PTBP1 Is Required for Embryonic Development before Gastrulation , 2011, PloS one.

[186]  M. Takeichi,et al.  Neural crest emigration from the neural tube depends on regulated cadherin expression. , 1998, Development.

[187]  M. Mareel,et al.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. , 2001, Journal of cell science.

[188]  Andrés J. García,et al.  p120-catenin and β-catenin differentially regulate cadherin adhesive function , 2013, Molecular biology of the cell.

[189]  S. Li,et al.  Numb: A new player in EMT. , 2010, Cell adhesion & migration.

[190]  K. Miyazawa,et al.  Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) Suppress Cancer Cell Motility via Different Mechanisms* , 2014, The Journal of Biological Chemistry.

[191]  H. Hanafusa,et al.  Abl Interactor 1 Promotes Tyrosine 296 Phosphorylation of Mammalian Enabled (Mena) by c-Abl Kinase* , 2003, Journal of Biological Chemistry.

[192]  M. Herlyn,et al.  Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. , 2010, Cancer research.

[193]  Nicholas C. Flytzanis,et al.  An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype , 2011, PLoS genetics.

[194]  R. Weinberg,et al.  Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. , 2015, Trends in cell biology.

[195]  R. Carstens,et al.  Heterogeneous Ribonucleoprotein M Is a Splicing Regulatory Protein That Can Enhance or Silence Splicing of Alternatively Spliced Exons* , 2007, Journal of Biological Chemistry.

[196]  G. Christofori,et al.  The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion , 2014, Oncogene.

[197]  Gene W. Yeo,et al.  An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells , 2009, Nature Structural &Molecular Biology.

[198]  U. Philippar,et al.  Human Mena+11a Isoform Serves as a Marker of Epithelial Phenotype and Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Pancreatic Cancer Cell Lines , 2008, Clinical Cancer Research.

[199]  Xin Hu,et al.  Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition , 2010, Oncogene.

[200]  Kerry J. Davies.  The Complex Interaction of Matrix Metalloproteinases in the Migration of Cancer Cells through Breast Tissue Stroma , 2014, International journal of breast cancer.

[201]  Tom Maniatis,et al.  Specific interactions between proteins implicated in splice site selection and regulated alternative splicing , 1993, Cell.

[202]  R. Knuechel,et al.  Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[203]  S. Ogawa,et al.  Splicing factor mutations and cancer , 2014, Wiley interdisciplinary reviews. RNA.

[204]  N. Webster,et al.  Deletion of serine/arginine‐rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice , 2015, Hepatology.

[205]  Amanda E. Jones,et al.  Snail2/Slug cooperates with Polycomb repressive complex 2 (PRC2) to regulate neural crest development , 2015, Development.

[206]  E. Carver,et al.  The Mouse Snail Gene Encodes a Key Regulator of the Epithelial-Mesenchymal Transition , 2001, Molecular and Cellular Biology.

[207]  A. Groves,et al.  Setting appropriate boundaries: fate, patterning and competence at the neural plate border. , 2014, Developmental biology.

[208]  E. Gottlieb,et al.  Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer. , 2012, Trends in biochemical sciences.

[209]  Prakash Kulkarni,et al.  Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing. , 2013, Cancer research.

[210]  B. Blencowe,et al.  An RNA map predicting Nova-dependent splicing regulation , 2006, Nature.

[211]  Anke Busch,et al.  Evolution of SR protein and hnRNP splicing regulatory factors , 2012, Wiley interdisciplinary reviews. RNA.

[212]  N. Matsuura,et al.  Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. , 2011, The Annals of thoracic surgery.

[213]  A. Hecht,et al.  Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/β-catenin targets , 2009, Nucleic acids research.

[214]  Hong Wu,et al.  Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. , 2015, Cancer research.

[215]  M. Bronner,et al.  Sip1 mediates an E-cadherin-to-N-cadherin switch during cranial neural crest EMT , 2013, The Journal of cell biology.

[216]  Leping Li,et al.  Oct4/Sox2-Regulated miR-302 Targets Cyclin D1 in Human Embryonic Stem Cells , 2008, Molecular and Cellular Biology.

[217]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[218]  Yi Xing,et al.  An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition , 2010, The EMBO journal.

[219]  A. Ghanate,et al.  Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53‐Mediated Apoptosis and Acquiring a Stem‐Like Phenotype in Ovarian Cancer Cells , 2009, Stem cells.

[220]  K. Helin,et al.  Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor , 2008, Molecular and Cellular Biology.

[221]  D. Radisky,et al.  The 19-Amino Acid Insertion in the Tumor-associated Splice Isoform Rac1b Confers Specific Binding to p120 Catenin* , 2010, The Journal of Biological Chemistry.

[222]  Claude C. Warzecha,et al.  ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. , 2009, Molecular cell.

[223]  Sigrid A. Langhans,et al.  Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition , 2014, Front. Oncol..

[224]  R. Simpson,et al.  Towards understanding epithelial-mesenchymal transition: a proteomics perspective. , 2009, Biochimica et biophysica acta.

[225]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[226]  P. Comoglio,et al.  A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype , 1996, Molecular and cellular biology.

[227]  Carien M Niessen,et al.  Tight junctions/adherens junctions: basic structure and function. , 2007, The Journal of investigative dermatology.

[228]  R. Cameron,et al.  Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. , 2006, Cancer research.

[229]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[230]  Pierre-Étienne Jacques,et al.  SON connects the splicing-regulatory network with pluripotency in human embryonic stem cells , 2013, Nature Cell Biology.

[231]  Claude C. Warzecha,et al.  Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). , 2012, Seminars in cancer biology.

[232]  Hong Wang,et al.  Rac1b enhances cell survival through activation of the JNK2/c-JUN/Cyclin-D1 and AKT2/MCL1 pathways , 2016, Oncotarget.

[233]  R. Storb,et al.  RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML. , 2016, Cell stem cell.

[234]  C. Scuoppo,et al.  Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells , 2012, PloS one.

[235]  M. Biffoni,et al.  CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. , 2014, Cell stem cell.

[236]  H. Miyake,et al.  Over expression of CD44V8-10 in human bladder cancer cells decreases their interaction with hyaluronic acid and potentiates their malignant progression. , 2004, The Journal of urology.

[237]  V. Vaira,et al.  Aberrant overexpression of the cell polarity module scribble in human cancer. , 2011, The American journal of pathology.

[238]  J. Tazi,et al.  MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation , 2013, Nature Communications.

[239]  Z. Q. Lim,et al.  Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention. , 2012, Genes & development.

[240]  Jignesh R. Parikh,et al.  Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. , 2014, Cell stem cell.

[241]  M. Moyer,et al.  Expression of tumor-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells. , 2015, Cancer letters.

[242]  N. Yoshida,et al.  Polypyrimidine tract‐binding protein is essential for early mouse development and embryonic stem cell proliferation , 2009, The FEBS journal.

[243]  B. Baum,et al.  Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling , 2011, The Journal of cell biology.

[244]  T. Möller,et al.  Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses. , 2009, Cancer research.